Anticholinergic News and Research

RSS
COPD phase III study by Almirall and Forest Laboratories announces positive results

COPD phase III study by Almirall and Forest Laboratories announces positive results

FDA approves Allergan’s BOTOX to treat overactive bladder

FDA approves Allergan’s BOTOX to treat overactive bladder

Tiotropium benefits patients with chronic obstructive pulmonary disease

Tiotropium benefits patients with chronic obstructive pulmonary disease

Almirall, Forest Laboratories' Tudorza Pressair now available in the U.S. pharmacies

Almirall, Forest Laboratories' Tudorza Pressair now available in the U.S. pharmacies

Oral medication as effective as Botox injections for treating incontinence in women

Oral medication as effective as Botox injections for treating incontinence in women

Botox injections effectively treat urinary urgency incontinence in women

Botox injections effectively treat urinary urgency incontinence in women

Multicomponent strategies needed to prevent in-hospital delirium

Multicomponent strategies needed to prevent in-hospital delirium

Combining tiotropium with olodaterol significantly improves lung function in COPD patients

Combining tiotropium with olodaterol significantly improves lung function in COPD patients

SPIRIVA to mark 10th anniversary with European Respiratory Society Congress

SPIRIVA to mark 10th anniversary with European Respiratory Society Congress

Pristine Solutions acquires Eaton Scientific Systems

Pristine Solutions acquires Eaton Scientific Systems

New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on asthma, COPD

New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on asthma, COPD

Be alert for arrhythmias in new bronchodilator patients, researchers say

Be alert for arrhythmias in new bronchodilator patients, researchers say

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

IACs may increase risk of arrhythmias in young individuals with asthma

IACs may increase risk of arrhythmias in young individuals with asthma

Astellas' mirabegron for OAB receives FDA advisory committee approval

Astellas' mirabegron for OAB receives FDA advisory committee approval

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients

Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Anticholinergic medications linked to risk of cognitive impairment, death in older population

Anticholinergic medications linked to risk of cognitive impairment, death in older population

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.